Clinical Trial Update: Ziprasidone in the Treatment of Borderline Personality Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ziprasidone for Borderline Personality Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED